Pulmonary Rehabilitation Post-COVID-19
1 other identifier
interventional
14
1 country
1
Brief Summary
The main objective of this pilot study was to evaluate the feasibility, safety, and satisfaction of a remote interdisciplinary PR program delivered using two exercise approaches (video conference and self-directed) on the recovery of long-term post-COVD-19 outcomes. The specific aims were i) to evaluate the effect of each of the approaches on patients': 1) lung capacity, 2) dyspnea and fatigue, 3) exercise capacity, 4) physical function, 5) participation, and 5) HRQoL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable covid19
Started Apr 2022
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 12, 2021
CompletedStudy Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedJanuary 3, 2024
December 1, 2023
5 months
August 6, 2021
December 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Feasibility of the program
This was determined according to the following criteria: (1) 70% of participants completed the PR program, (2) data on primary outcomes collected in ≥ 70% of participants after the PR program, and (3) \< 10% of adverse events related to the intervention.
8 weeks (end of the study)
Recruitment rate
Calculated as percentage of potentially eligible participants that were recruited.
8 weeks (beginning of the study)
Intervention completion rate
Calculated as the percentage of sessions attended by participants. The number of sessions in the vide conference group was recorded by the therapist who attended Zoom meeting, whereas those in the self-directed group were asked to record the number of sessions in the diary.
8 weeks
Dropout rate
Calculated as the proportion of individuals who ceased participation after randomization and before completing 80% of sessions due to adverse events or personal preferences.
8 weeks
Patient safety
Represented as the incidence of adverse events caused by the interventions.
8 weeks
Patient satisfaction with the program
Participants will complete a short summary with questions regarding their satisfaction with the study
after 8 weeks (end of the study)
Secondary Outcomes (9)
Change in lung capacity
8 weeks
Change in dyspnea
8 weeks
Changes in fatigue severity assessed with the Fatigue Severity Scale
8 weeks
Changes in fatigue assesses with the DePaul Symptom Questionnaire short-form
8 weeks
Change in sit-to-stand capacity
8 weeks
- +4 more secondary outcomes
Study Arms (2)
Small group zoom meeting
EXPERIMENTALGroup one: participants were asked to follow the exercise program with a small group of peers (2 groups/6 participants each) in a Zoom meeting 3 times a week/45 min each (including 5 min before and 10 min after the meeting for free talk-chat between the participants; e.g., questions, perceptions, etc.).
YouTube pre-recorded video
EXPERIMENTALGroup two: participants were asked to follow the exercise program 3 times a week/30 min each while watching a pre-recorded YouTube video.
Interventions
Intervention (8 weeks): using the participants' initial assessment and personal characteristics, the therapist will provide personalized recommendations (e.g. maximum heart rate, minimum SpO2), explain the educational materials, and instruct patients on safety precautions.
Eligibility Criteria
You may qualify if:
- Post-COVID-19 ≥ 3 months after infection.
- Mild to severe persistent respiratory symptoms
- Access to a smart phone, tablet or computer, and home internet
You may not qualify if:
- History of neurological disease or mental illness
- Inability to ambulate independently without supervision
- Inability to complete basic tasks on a smart phone or tablet
- Did not return calls after the initial contact
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- Health Sciences Centre Foundation, Manitobacollaborator
- Health Sciences Centre, Winnipeg, Manitobacollaborator
Study Sites (1)
U of Manitoba
Winnipeg, Manitoba, R3E 0T6, Canada
Related Publications (1)
Sarmento A, Adodo R, Hodges G, Webber SC, Sanchez-Ramirez DC. Virtual pulmonary rehabilitation approaches in patients with post COVID syndrome: a pilot study. BMC Pulm Med. 2024 Mar 18;24(1):139. doi: 10.1186/s12890-024-02965-3.
PMID: 38500051DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diana C Sanchez-Ramirez, PhD
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
August 6, 2021
First Posted
August 12, 2021
Study Start
April 4, 2022
Primary Completion
August 30, 2022
Study Completion
October 1, 2023
Last Updated
January 3, 2024
Record last verified: 2023-12